| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/24/2002 | CN1359923A Polypeptide-human Parkinson syndrome related protein 9.68 and polynucleotide for coding it |
| 07/24/2002 | CN1359922A Polypeptide-human zinc finger protein 14.74 and polynucleotide for coding it |
| 07/24/2002 | CN1359921A Polypeptide-human transcriptional activator protein 16.5 and polynucleotide for coding it |
| 07/24/2002 | CN1359920A Polypeptide-human differential development related protein 15.95 and polynucleotide for coding it |
| 07/24/2002 | CN1359919A Polypeptide-human transcriptional regulatory factor 12.10 and polynucleotide for coding it |
| 07/24/2002 | CN1359918A Polypeptide-interferon protein 18.04 and polynucleotide for coding it |
| 07/24/2002 | CN1359917A Polypeptide-human zinc finger protein 11.88 and polynucleotide for coding it |
| 07/24/2002 | CN1359916A Polypeptide-human zinc finger protien 10.67 and polynucleotide for coding it |
| 07/24/2002 | CN1359915A Polypeptide-cell division cycle regulatory protein 137.17 and polynucleotide for coding it |
| 07/24/2002 | CN1359914A Polypeptide-cell division cyche regulatory protein 107.14 and polynucleotide for coding it |
| 07/24/2002 | CN1359913A Polypeptide-extracellular stromatin 3-61 and polynucleotide for coding it |
| 07/24/2002 | CN1359912A Polypeptide-sigma-54 factor 9.79 and polynucleotide for coding it |
| 07/24/2002 | CN1359911A Polypeptide-Fe regulatory protein 38.39 and polynucleotide for coding it |
| 07/24/2002 | CN1359910A Polypeptide-cytotoxin immunocyte subunit 11.77 and polynucleotide for coding it |
| 07/24/2002 | CN1359909A Polypeptide-renal cell tumor antigen protein-37-32 and polynucleotide for coding it |
| 07/24/2002 | CN1359908A Polypeptide-human topoisomerase 10.67 and polynucleotide for coding it |
| 07/24/2002 | CN1359907A Polypeptide-transposon factor 10.56 and polynucleotide for coding it |
| 07/24/2002 | CN1359906A Polypeptide-high-mobility component protein 12.87 and polynucleotide for coding it |
| 07/23/2002 | US6423836 Production and use of human nm23 protein and antibodies therefor |
| 07/23/2002 | US6423835 Medical diagnosis of infections; vaccines; genetic engineering and expression |
| 07/23/2002 | US6423828 Genetically engineered insecticidal endotoxins |
| 07/23/2002 | US6423824 Cd2 associated intracellular polypeptide capable of binding to intracellular domain |
| 07/23/2002 | US6423546 Monoclonal antibodies for assaying lipid transfer proteins |
| 07/23/2002 | US6423527 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 07/23/2002 | US6423521 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/23/2002 | US6423513 Polynucleotide encoding proprotein comprising cell recognition domain binding to exterior surface of targeted cell, domain effecting translocation to cell cytosol upon proteolytic cleavage, cytotoxicity domain, endoplasmic reticulum retention |
| 07/23/2002 | US6423511 Humanized antibodies |
| 07/23/2002 | US6423508 Polynucleotide sequences of human EDG-1c |
| 07/23/2002 | US6423507 Detecting enzyme inhibitors; obtain protease, incubate with modulator, monitor adjustment in protease activity |
| 07/23/2002 | US6423506 Immunoglobulin for use in food processing, food treatment and evaluting food safety |
| 07/23/2002 | US6423505 Methods and reagents for quantitation of HLA-DR and CD11b expression on peripheral blood cells |
| 07/23/2002 | US6423504 Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof |
| 07/23/2002 | US6423502 Method for screening candidate pesticides using a receptor that binds Bacillus thuringiensis toxin |
| 07/23/2002 | US6423501 Calcium-independent negative regulation by CD81 of receptor signaling |
| 07/23/2002 | US6423496 Nucleotide sequences for use in the detection, diagnosis and monitoring of mammary gland tumors |
| 07/23/2002 | US6423321 Administering therapeutically effective dosage level to human of etanercept for reducing inflammation or for modulating immune response affecting auditory apparatus |
| 07/23/2002 | US6423314 For inhibiting metastasis of a tumor cell of the type expressing a galactose-specific, carbohydrate binding |
| 07/23/2002 | US6423313 Inhibition of tumor growth by blockade of the protein C system |
| 07/23/2002 | US6423312 Compositions including glycosaminoglycans degrading enzymes and use of same against surface protected bacteria |
| 07/23/2002 | CA2368791A1 Medicament for the protection against thrombotic diseases |
| 07/23/2002 | CA2365997A1 Novel polypeptide |
| 07/23/2002 | CA2303598C Tandem immuno-assay for cancer |
| 07/23/2002 | CA2168440C Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer |
| 07/23/2002 | CA2091769C Framework mutated antibodies and their preparation |
| 07/23/2002 | CA2072642C Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
| 07/23/2002 | CA2066221C Conjugate vaccine for group b streptococcus |
| 07/23/2002 | CA2042503C Novel bifunctional linking compounds, conjugates and methods for their production |
| 07/18/2002 | WO2002055738A2 Molecules for disease detection and treatment |
| 07/18/2002 | WO2002055735A2 Compositions and methods relating to prostate specific genes and proteins |
| 07/18/2002 | WO2002055726A2 Detection and alteration of mhc class ii presentation phenotypes |
| 07/18/2002 | WO2002055725A2 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production |
| 07/18/2002 | WO2002055718A2 Assembly and screening of highly complex and fully human antibody repertoire in yeast |
| 07/18/2002 | WO2002055706A2 Asip-related proteins |
| 07/18/2002 | WO2002055705A2 Proteins and nucleic acids encoding same |
| 07/18/2002 | WO2002055700A2 Human genes and gene expression products isolated from human prostate |
| 07/18/2002 | WO2002055697A2 Human rhinovirus assays, and compositions comprising anti-rhinoviral perturbagens |
| 07/18/2002 | WO2002055696A1 Mast cell surface antigen, dna thereof and antibody against the antigen |
| 07/18/2002 | WO2002055690A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/18/2002 | WO2002055668A2 Nucleotide sequences encoding variable regions of heavy and light chains of monoclonal antibody 1f7 |
| 07/18/2002 | WO2002055560A2 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c |
| 07/18/2002 | WO2002055559A1 Dna vaccines expressing hypervariable vh-cdr3 idiotipic determinants |
| 07/18/2002 | WO2002055555A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 07/18/2002 | WO2002055552A2 Soluble cyclic analogues of beta amyloid peptide |
| 07/18/2002 | WO2002055109A2 Generation and/or reduction of new lung tissue in an affected lung, by modulation of the wnt-pathway |
| 07/18/2002 | WO2002055106A2 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 07/18/2002 | WO2002055100A2 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 07/18/2002 | WO2002055089A2 Immunoassay technique using multispecific molecules |
| 07/18/2002 | WO2002028414B1 Compositions and methods for wt1 specific immunotherapy |
| 07/18/2002 | WO2002028351A3 Recombinant mucin binding proteins from steptococcus pneumoniae |
| 07/18/2002 | WO2002027322A3 Reagents, method and kit for detecting phosphinothricin-n-acetyltransferase protein |
| 07/18/2002 | WO2002024752A3 Monoclonal antibodies against lipid structures different from the double layer of cell membranes for defining physiological states in different cell types and detecting anti lipid particle antibodies in human beings and/or animals suffering from certain antiphospholipid antibody-related diseases |
| 07/18/2002 | WO2002012535B1 Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotherapy |
| 07/18/2002 | WO2002006311A3 Olfactory g-protein coupled receptor |
| 07/18/2002 | WO2002004522A3 Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
| 07/18/2002 | WO2002004020A3 Pathogen resistance in organisms |
| 07/18/2002 | WO2002002633A3 Transporters and ion channels |
| 07/18/2002 | WO2002002143A3 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 07/18/2002 | WO2001094391A3 Intracellular signaling proteins |
| 07/18/2002 | WO2001090328A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/18/2002 | WO2001088132A3 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods |
| 07/18/2002 | WO2001087980A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 07/18/2002 | WO2001085798A3 Human monoclonal antibodies to dendritic cells |
| 07/18/2002 | WO2001085790A3 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 07/18/2002 | WO2001085783A3 Nucleic acids encoding polypeptides related to the alpha subunit of the glycoprotein hormone family and methods of use thereof |
| 07/18/2002 | WO2001083749A3 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
| 07/18/2002 | WO2001083525A3 Modified peptides, comprising an fc domain, as therapeutic agents |
| 07/18/2002 | WO2001081590A3 Protein phosphatases |
| 07/18/2002 | WO2001081544A3 Identification and uses of a hyaluronan receptor |
| 07/18/2002 | WO2001079468A3 Drug metabolizing enzymes |
| 07/18/2002 | WO2001079282A3 Molecules associated with human reproduction |
| 07/18/2002 | WO2001072822A3 Genes involved in intestinal inflammatory diseases and use thereof |
| 07/18/2002 | WO2001068705A3 Il-17 receptor like molecules and uses thereof |
| 07/18/2002 | WO2001066747A3 Proteins named fctrx and nucleic acids encoding same |
| 07/18/2002 | WO2001055309A3 Nucleic acids, proteins, and antibodies |
| 07/18/2002 | WO2001055304A3 Nucleic acids, proteins, and antibodies |
| 07/18/2002 | WO2001051520A9 Nogo receptor-mediated blockade of axonal growth |
| 07/18/2002 | WO2001040493A3 Schizophrenia associated gene, proteins and biallelic markers |
| 07/18/2002 | WO2001040310A3 Immobilisation of proteins using a polypeptide segment |
| 07/18/2002 | WO2001005834A9 Human tumor necrosis factor receptors tr13 and tr14 |
| 07/18/2002 | WO2000078972A9 Regulation with binding cassette transporter protein abc1 |